BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 7308514)

  • 21. Discordant responses of prolactinoma to two different dopamine agonists.
    Ahmed SR; Shalet SM
    Clin Endocrinol (Oxf); 1986 Apr; 24(4):421-6. PubMed ID: 3742834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of bromocriptine and pergolide on pituitary tumor size and serum prolactin.
    Horowitz BL; Hamilton DJ; Sommers CJ; Bryan RN; Boyd AE
    AJNR Am J Neuroradiol; 1983; 4(3):415-7. PubMed ID: 6410759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT follow-up of microprolactinomas during bromocriptine-induced pregnancy.
    Dietemann JL; Portha C; Cattin F; Mollet E; Bonneville JF
    Neuroradiology; 1983; 25(3):133-8. PubMed ID: 6888713
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Computed tomographic demonstration of the effects of bromocriptine on pituitary microadenoma size.
    Bonneville JF; Poulignot D; Cattin F; Couturier M; Mollet E; Dietemann JL
    Radiology; 1982 May; 143(2):451-5. PubMed ID: 7071347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid rhinorrhea caused by bromocriptine therapy of prolactinoma.
    Holness RO; Shlossberg AH; Heffernan LP
    Neurology; 1984 Jan; 34(1):111-3. PubMed ID: 6537833
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions between thioridazine and bromocriptine in a patient with a prolactin-secreting pituitary adenoma.
    Robbins RJ; Kern PA; Thompson TL
    Am J Med; 1984 May; 76(5):921-3. PubMed ID: 6720732
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in computed tomographic findings in microprolactinomas before and after bromocriptine.
    Demura R; Kubo O; Demura H; Shizume K; Kitamura K
    Acta Endocrinol (Copenh); 1985 Nov; 110(3):308-12. PubMed ID: 4072572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bromocriptine: Does it jeopardise the result of later surgery for prolactinomas?
    Landolt AM; Keller PJ; Froesch ER; Mueller J
    Lancet; 1982 Sep; 2(8299):657-8. PubMed ID: 6125789
    [No Abstract]   [Full Text] [Related]  

  • 29. Size reduction of a large prolactinoma by bromocriptine treatment. Report of a case.
    Matsumura S; Mori S; Uozumi T
    Neurol Med Chir (Tokyo); 1981 Jan; 21(1):127-30. PubMed ID: 6168944
    [No Abstract]   [Full Text] [Related]  

  • 30. Enlargement of a prolactin-secreting pituitary microadenoma during bromocriptine treatment. Case report.
    Crosignani PG; Mattei A; Ferrari C; Giovanelli MA
    Br J Obstet Gynaecol; 1982 Feb; 89(2):169-70. PubMed ID: 7066250
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Persisting suppression of prolactin secretion after long-term treatment with bromocriptine in patients with prolactinomas.
    Eversmann T; Fahlbusch R; Rjosk HK; von Werder K
    Acta Endocrinol (Copenh); 1979 Nov; 92(3):413-27. PubMed ID: 574700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Radiological control of prolactin adenomas treated with bromocriptine].
    Metzger J; Gardeur D; Pehuet M; Houlbert D
    Ann Med Interne (Paris); 1982; 133(1):59-60. PubMed ID: 7065592
    [No Abstract]   [Full Text] [Related]  

  • 33. Cavernous sinus syndrome due to prolactinoma: resolution with bromocriptine.
    King LW; Molitch ME; Gittinger JW; Wolpert SM; Stern J
    Surg Neurol; 1983 Mar; 19(3):280-4. PubMed ID: 6836484
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The long-term effects of pregnancy and bromocriptine treatment on prolactinomas--the value of radiologic studies.
    Badawy SZ; Marziale JC; Rosenbaum AE; Chang JK; Joy SE
    Early Pregnancy; 1997 Dec; 3(4):306-11. PubMed ID: 10086082
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
    Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
    Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Size reduction of a nonfunctioning pituitary adenoma after bromocriptine therapy: case report].
    Takahashi T; Kuwayama A; Katoh T; Ichihara K; Kageyama N; Sasaki F
    No Shinkei Geka; 1984 Jan; 12(1):71-80. PubMed ID: 6717737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rapid size reduction of giant prolactinoma following medical treatment.
    Perani D; Colombo N; Scotti G; Tonon C
    J Comput Assist Tomogr; 1984 Feb; 8(1):131-3. PubMed ID: 6690496
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transient intrasellar collection of air during bromocriptine treatment of a prolactinoma.
    Fagel WJ; Hekster RE; Smith SJ; van der Vijver JC
    Neuroradiology; 1986; 28(4):364-6. PubMed ID: 3762918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bromocriptine reduces the size of cells in prolactin-secreting pituitary adenomas.
    Landolt AM; Minder H; Osterwalder V; Landolt TA
    Experientia; 1983 Jun; 39(6):625-6. PubMed ID: 6852202
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Visual function in prolactinoma patients treated with bromocriptine.
    Moster ML; Savino PJ; Schatz NJ; Snyder PJ; Sergott RC; Bosley TM
    Ophthalmology; 1985 Oct; 92(10):1332-41. PubMed ID: 4069600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.